Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications development patient reported assessment identify placebo responders generalized anxiety
… product value to support successful reimbursement and patient access. Creating a strategic plan with a Market Access Evidence Roadmap can help you identify areas of evidence generation you will need down the road. It can make your development process more efficient by preventing delays and …
… by allowing payers to plan and budget for products in development. Sharing pre-approval/clearance information with … study protocols about endpoints being studied and the patient population under investigation Anticipated timeline … the product or of the new use Product pricing information Patient utilization projections such as epidemiological data …
Informing Gestational Age in Pregnancy Research without Clinical Estimates Distribution of gestational age by maternal and infant characteristics in US birth certificate data: toward informing gestational age assumptions when clinical estimates are not …
… Asset Value Through Evidence Generation Planning In the development of new medical products, it is important to … on treatment value to support successful reimbursement and patient access. In order to be better prepared for a … launch, a Market Access Evidence Roadmap can help you identify areas of evidence generation required to support …
… Solutions experts will be presented at DIA 2024. Effective patient engagement in patient experience data: practical insights from case studies … post-marketing safety studies, with use cases provided. Identify specific study design and analytic challenges …
… studies in Medicare populations. These studies reported real-world evidence on how treatment types can … often require medical intervention and may disrupt a patient’s treatment schedule, which in turn can lead to … Study measures and endpoints were as follows: Baseline patient characteristics Treatment characteristics Overall …
… devices, and biological products. Sponsors will need to identify potential obstacles to enrollment, such as … Research (WONDER) Department of Housing and Urban Development (HUD) Child Opportunity Index (COI) Opportunity …
… real-world evidence depends on being able to accurately identify exposures of interest in real-world data. US …
… Disease and Ulcerative Colitis (GETECCU), holds ENEIDA patient register SWEDEN Karolinska Institute UNITED KINGDOM …
… with other data could allow RTI-HS or its vendor to identify you. We may also collect the following categories … collected or obtained will not allow RTI-HS to directly identify you. RTI-HS will treat any Personal Data you … participants in the study, it will not be possible to identify your data separately or remove it from the study …